TEVA PHARMACEUTICAL INDUSTRIES LIMITED Accumulated Amortization, Debt Issuance Costs, Noncurrent
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Accumulated Amortization, Debt Issuance Costs, Noncurrent of $6.00 million as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Debt › Debt Issuance Costs, Noncurrent, Net
us-gaap:AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts · last filed 2026-02-03
- 2025-12-31: Accumulated Amortization, Debt Issuance Costs, Noncurrent $6.00M.
- 2025-09-30: Accumulated Amortization, Debt Issuance Costs, Noncurrent $6.00M.
- 2025-06-30: Accumulated Amortization, Debt Issuance Costs, Noncurrent $6.00M.
| Period end | Accumulated Amortization, Debt Issuance Costs, Noncurrent |
|---|---|
| 2025-12-31 | $6.00M 10-K · filed 2026-02-03 |
| 2025-09-30 | $6.00M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $6.00M 10-Q · filed 2025-07-30 |